Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$2.49 USD
-0.08 (-3.11%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $2.50 +0.01 (0.40%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
AVAH 2.49 -0.08(-3.11%)
Will AVAH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AVAH
Compared to Estimates, Aveanna (AVAH) Q1 Earnings: A Look at Key Metrics
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Countdown to Aveanna (AVAH) Q1 Earnings: Wall Street Forecasts for Key Metrics
Addus HomeCare (ADUS) Q1 Earnings and Revenues Beat Estimates
Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for AVAH
Aveanna Healthcare Enhances Investor Communication with Presentation
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Polen Capital Q1 2024 Credit Opportunities Full Discretion Composite Commentary